Albemarle Corporation $ALB Stock Holdings Increased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lifted its holdings in Albemarle Corporation (NYSE:ALB) by 57.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,978 shares of the specialty chemicals company’s stock after buying an additional 19,399 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Albemarle were worth $5,604,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of ALB. Primecap Management Co. CA purchased a new stake in Albemarle in the second quarter worth about $358,101,000. Deutsche Bank AG purchased a new position in shares of Albemarle during the second quarter valued at approximately $131,049,000. Bank of New York Mellon Corp bought a new stake in shares of Albemarle in the 2nd quarter worth approximately $103,268,000. Robeco Institutional Asset Management B.V. boosted its position in shares of Albemarle by 2,981.1% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock worth $77,621,000 after purchasing an additional 709,977 shares in the last quarter. Finally, ProShare Advisors LLC grew its stake in shares of Albemarle by 69.7% in the 3rd quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock worth $151,912,000 after buying an additional 589,787 shares during the last quarter. 92.87% of the stock is currently owned by institutional investors.

Key Albemarle News

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Albemarle reported third-quarter adjusted earnings of $2.58 per share, ahead of estimates, on $1.55 billion in revenue—also above forecasts and up 18.8% year over year. Higher lithium pricing, strong demand, cost reductions and improved Specialties profits supported the results. Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand
• Positive Sentiment: Scotiabank maintained its “Sector Outperform” rating and $190 price target, estimating EPS of $11.64 for FY2026 and $14.15 for FY2027—above the cited current-year consensus estimate. Albemarle analyst coverage
• Positive Sentiment: Truist reaffirmed its “buy” rating, though it lowered its price target to $170 from $185. Truist rating information
• Neutral Sentiment: RBC cut its target to $119 from $129 but retained an “outperform” rating, reflecting a more cautious valuation alongside continued optimism about the shares. RBC rating information
• Negative Sentiment: Barclays lowered its target to $95 from $109 and kept an “equal weight” rating, pointing to a less favorable near-term risk-reward view. Lithium prices remain volatile, a potential source of uncertainty for earnings. Barclays rating information

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ALB. Truist Financial reiterated a “buy” rating and set a $170.00 price objective (down from $185.00) on shares of Albemarle in a research note on Friday. Wall Street Zen cut shares of Albemarle from a “buy” rating to a “hold” rating in a report on Saturday. Citigroup decreased their target price on shares of Albemarle from $175.00 to $125.00 and set a “buy” rating for the company in a report on Thursday, October 22nd. UBS Group dropped their target price on shares of Albemarle from $175.00 to $150.00 and set a “buy” rating on the stock in a research note on Monday, October 5th. Finally, Morgan Stanley reissued a “reduce” rating and set a $161.00 price target on shares of Albemarle in a research report on Monday, August 10th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $177.64.

Albemarle Stock Performance

Shares of Albemarle stock traded up $0.66 during trading on Friday, hitting $99.03. 2,444,312 shares of the company’s stock traded hands, compared to its average volume of 2,458,542. Albemarle Corporation has a 1 year low of $89.77 and a 1 year high of $221.00. The business has a 50-day simple moving average of $107.59 and a 200-day simple moving average of $147.87. The stock has a market capitalization of $11.69 billion, a P/E ratio of 23.92, a PEG ratio of 0.54 and a beta of 1.34. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.09 and a quick ratio of 1.35.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.05. The business had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.52 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.19) EPS. As a group, analysts forecast that Albemarle Corporation will post 11.20 EPS for the current year.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Friday, December 18th. Albemarle’s dividend payout ratio is 39.61%.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.